FDA Inspection
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Dongjin Road Site)Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Dongjin Road Site) – FDA Inspection, Aug 29, 2023
Record Details
This FDA Inspection record concerns Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Dongjin Road Site), with an inspection on August 29, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- August 29, 2023
- Product Type
- Drugs
View Company Profile
ID · 98209768-4c21-453c-a664-bfc91b0894f5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1222323
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Dongjin Road Site)
2| Date | Classification | Office | Project area |
|---|---|---|---|
| July 3, 2026 | Not classified | Office of Inspections and Investigations | |
| August 24, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Dongjin Road Site)
- FDA Inspection 1330154 - 2026-07-03
- FDA Inspection 943139 - 2015-08-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.